PDC*line Pharma SAS

[Sidebar#SC145549] Biopharmaceutical companies and other life science start-ups may access $1.28bn in new venture capital available through four different sources, including Eir Venture Partners AB’s

The Europe-based biotech firm, PDC*line Pharma has benefited from its visibility in Asia by attracting institutional and VC investors from South Korea to its series B funding round, which has just r

Venture capital investment in biopharmaceutical companies during 2019 fell from the records set in 2018, but still came in second place by a wide margin, according to recent year-end wrap-ups – Silico

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Takeda Partners With LegoChe